Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HUCKER HB")

Results 1 to 21 of 21

  • Page / 1
Export

Selection :

  • and

RAPID, SENSITIVE GAS-LIQUID CHROMATOGRAPHIC METHOD FOR DETERMINATION OF AMITRIPTYLINE AND NORTRIPTYLINE IN PLASMA USING A NITROGEN-SENSITIVE DETECTOR.HUCKER HB; STAUFFER SC.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 138; NO 2; PP. 437-442; BIBL. 13 REF.Article

DETERMINATION OF VARIOUS DRUGS IN RODENT DIET MIXTURES.HUCKER HB; STAUFFER SC.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 131; PP. 357-363; BIBL. 4 REF.Article

GLC DETERMINATION OF CYCLOBENZAPRINE IN PLASMA AND URINE.HUCKER HB; STAUFFER SC.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 8; PP. 1253-1255; BIBL. 6 REF.Article

GLC ANALYSIS OF LIDOCAINE IN PLASMA USING A NOVEL NITROGEN-SENSITIVE DETECTOR. = ANALYSE DE LA LIDOCAINE DANS LE PLASMA PAR CHROMATOGRAPHIE EN PHASE GAZEUSE EN UTILISANT UN NOUVEAU DETECTEUR SENSIBLE DE L'AZOTEHUCKER HB; STAUFFER SC.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 6; PP. 926-927; BIBL. 15 REF.Article

PHARMACOKINETICS AND METABOLISM OF NON-STEROIDAL ANTI-INFLAMMATORY AGENTSHUCKER HB; KWAN KC; DUGGAN DE et al.1980; PROGR. DRUG METABOL.; GBR; DA. 1980; VOL. 5; PP. 165-253; BIBL. 12 P.Article

EFFECT OF HALOFENATE ON BINDING OF VARIOUS DRUGS TO HUMAN PLASMA PROTEINS AND ON THE PLASMA HALF-LIFE OF ANTIPYRINE IN MONKEYS = EFFET DE L'HALOFENATE SUR LA FIXATION DE DIVERS MEDICAMENTS AUX PROTEINES DU PLASMA HUMAIN ET SUR LA DEMI-VIE PLASMATIQUE DE L'ANTIPYRINE CHEZ LES SINGESHUCKER HB; STAUFFER SC; WHITE SE et al.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 9; PP. 1490-1492; BIBL. 17REF.Serial Issue

COMPARATIVE DISPOSITION OF SULINDAC AND METABOLITES IN FIVE SPECIESDUGGAN DE; HOOKE KF; NOLL RM et al.1978; BIOCHEM. PHARMACOL.; GBR; DA. 1978; VOL. 27; NO 19; PP. 2311-2320; BIBL. 17 REF.Article

METABOLISM OF CYCLOBENZAPRINE IN THE DOG.HUCKER HB; BALLETTO AJ; ARISON H et al.1978; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1978; VOL. 6; NO 2; PP. 184-192; BIBL. 27 REF.Article

PLASMA LEVELS AND BIOAVAILABILITY OF CYCLOBENZAPRINE IN HUMAN SUBJECTS.HUCKER HB; STAUFFER SC; ALBERT KS et al.1977; J. CLIN. PHARMACOL.; U.S.A.; DA. 1977; VOL. 17; NO 11-12; PP. 719-727; BIBL. 9 REF.Article

PHYSIOLOGICAL DISPOSITION AND URINARY METABOLITES OF CYPROHEPTADINE IN THE DOG, RAT, AND CATHUCKER HB; BALLETTO AJ; STAUFFER SC et al.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 5; PP. 406-415; BIBL. 13 REF.Article

FURTHER STUDIES ON THE METABOLISM OF CARBIDOPA, (-)-L-ALPHA -HYDRAZINO-3,4-DIHYDROXY-ALPHA -METHYL BENZENE PROPANOIC ACID MONOHYDRATE, IN THE HUMAN, RHESUS MONKEY, DOG, AND RATVICKERS S; STUART EK; HUCKER HB et al.1975; J. MEDICIN. CHEM.; U.S.A.; DA. 1975; VOL. 18; NO 2; PP. 134-138; BIBL. 19 REF.Article

THE DISPOSITION AND METABOLISM OF AN OREXIGENIC AGENT, 10, 11-DIHYDRO-5-(1-METHYL-4-PIPERIDINYLIDENE)-5H-DIBENZO (A, D) CYCLOHEPTEN-3-CARBOXYLIC ACID, IN THE RAT, DOG, AND CATHUCKER HB; BALLETTO AJ; WHITE SD et al.1981; DRUG METAB. DISPOS.; ISSN 0090-9556; USA; DA. 1981; VOL. 9; NO 5; PP. 428-433; BIBL. 9 REF.Article

METABOLISM OF PROTRIPTYLINE BY RABBIT LIVER IN VITROHUCKER HB; BALLETTO AJ; ZACCHEI AG et al.1979; PHARMACOLOGY; CHE; DA. 1979; VOL. 19; NO 5; PP. 278-281; BIBL. 9 REF.Article

URINARY METABOLITES OF AMITRIPTYLINE IN THE DOG.HUCKER HB; BALLETTO AJ; DEMETRIADES J et al.1977; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1977; VOL. 5; NO 2; PP. 132-142; BIBL. 20 REF.Article

PLASMA LEVELS OF A NEW PELLITIZED FORM OF AMITRIPTYLINE FOR MAINTENANCE THERAPYHUCKER HB; STAUFFER SC; CLAYTON FG et al.1975; J. CLIN. PHARMACOL.; U.S.A.; DA. 1975; VOL. 15; NO 2-3; PP. 168-172; BIBL. 10REF.Article

PHYSIOLOGIC DISPOSITION AND METABOLISM OF AN ANTI-ULCER AGENT, N-(2-DIISOPROPYLAMINOETHYL)-N-(4,6-DIMETHYL-2-PYRIDYL)-N',N'-DIMETHYLU REA, IN RATS, DOGS, AND MONKEYSHUCKER HB; STAUFFER SC; WHITE SD et al.1982; DRUG METAB. DISPOS.; ISSN 0090-9556; USA; DA. 1982; VOL. 10; NO 1; PP. 28-34; BIBL. 2 REF.Article

BIOAVAILABILITY ASSESSMENT UNDER QUASI- AND NONSTEADY-STATE CONDITIONS III: APPLICATION.BONDI JV; HUCKER HB; YEH KC et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 11; PP. 1657-1665; BIBL. 8 REF.Article

PHYSIOLOGICAL DISPOSITION AND METABOLISM OF TIMOLOL IN MAN AND LABORATORY ANIMALS.TOCCO DJ; DUNCAN AEW; DELUNA FA et al.1975; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1975; VOL. 3; NO 5; PP. 361-370; BIBL. 12 REF.Article

PHYSIOLOGICAL DISPOSITION AND METABOLISM OF CYCLOBENZAPRINE IN THE RAT, DOG, RHESUS MONKEY, AND MANHUCKER HB; STAUFFER SC; BALLETTO AJ et al.1978; DRUG METABOL. DISPOSIT; USA; DA. 1978; VOL. 6; NO 6; PP. 659-672; BIBL. 16 REF.Article

THE EFFECT OF HALOGENATE OR HALOGENATE FREE ACID ON HUMAN, RAT AND GUINEA PIG PLATELET AGGREGATION.MINSKER DH; JORDAN PT; KLING P et al.1976; THROMBOSIS AND HAEMOSTASIS; GERM.; DA. 1976; VOL. 35; NO 2; PP. 358-363; ABS. FR. ALLEM.; BIBL. 7 REF.Article

METABOLISM OF CARBIDOPA (L-(-)-ALPHA -HYDRAZINO-3-4-DIHYDROXY-ALPHA -METHYLHYDROCINNAMIC ACID MONOHYDRATE), AN AROMATIC AMINO ACIDE DECARBOXYLASE INHIBITOR, IN THE RAT, DOG, RHESUS MONKEY, AND MAN = METABOLISME DU CARBIDOPA (MONOHYDRATE DE L'ACIDE L-(-)-ALPHA -HYDRAZINO DIHYDROXY-3,4 ALPHA -METHYL HYDROXY ANNAMIQUE), UN INHIBITEUR DE LA DECARBOXYLASE DES AMINOACIDES, CHEZ LE RAT, LE CHIEN, LE SINGE RHESUS ET CHEZ L'HOMMEVICKERS S; STUART EK; BIANCHINE JR et al.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 1; PP. 9-22; BIBL. 22 REF.Article

  • Page / 1